videogamesthatpaycrypto| Lilly adds "slimming drugs": announced an investment of US$5.3 billion to expand production capacity

Lilly adds "slimming pills"videogamesthatpaycrypto: Announced an investment of US$5.3 billion to expand production capacity

Source: Zhao Ying from Wall Street

This is the largest in the company's nearly 150-year historyvideogamesthatpaycryptoan investment.

Eli Lilly has made a major decision to invest $5.3 billion to increase the production of tirzepatide, a key ingredient in its weight loss and diabetes injections, media reported on Friday.

This investment not only adds to existing plans, but is also the largest investment in the company's nearly 150-year history.

This will expand its manufacturing facility in Indiana, which makes tirzepatide, the active ingredient of Zepbound diet drug and diabetes blockbuster Mounjaro.